Method Development & Validation
Developing Methods That Work in Your Lab—Not Just Ours
Quantum Analytics Group develops, remediates, optimizes, validates, verifies, and transfers analytical methods for pharmaceuticals, cosmetics, personal-care products, raw materials, and complex specialty products.
Whether you need a new stability-indicating method, an existing procedure is producing inconsistent results, or a method has failed transfer, you work directly with experienced scientists who identify the underlying cause and develop a fit-for-purpose solution that performs reliably in the real world.
Complete Analytical Method Development Expertise
New analytical method development
Method optimization and refinement
Stability-indicating method development
Method validation and verification
Method remediation and troubleshooting
USP <1224> Method Transfer
USP <1226> Compendial Verification
USP <1224> Method Transfer
Forced degradation study design
Regulatory-response support

CHOOSE THE SUPPORT YOU NEED
Method Support Matched To Your Actual Problem
Start with a defined project or an analytical challenge that still needs to be diagnosed. Quantum can support the procedure from initial feasibility through implementation and transfer. Our scientists work collaboratively with your team, helping you retain control while adding specialized expertise where it matters most.
Develop a New Method
Build a fit-for-purpose procedure for identity, assay, potency, purity, impurities,contaminants or stability testing.Optimize or Remediate
Investigate poor recovery, inconsistent precision, matrix interference, insufficient sensitivity, long run times, or recurring method failures.Validate or Verify
Generate documented evidence that an analytical procedure is suitable for its intended use and required performanceTransfer Successfully
Prepare and support transfer into an internal QC laboratory, manufacturing site or another contract laboratory.Analytical Applications
Assay and potency
Identity
Purity
Related Substances
Degradation Products
Trace Impurities
Stability Indicating
Raw Material & Excipient Testing
Lifecycle Services
Feasibility Assessment
New Method
Development
Method Optimization
Method Remediation
Method Qualification
Full or partial VAlidation
Compendial Method
Verification
Revalidation and Transfer
Validation Characteristics
Accuracy
Repeatability
Intermediate Precision
Lineraity and Range
Specificity and Selectivity
Detection and Quantitation Limits
Robustness
System Suitability
Sample and Standard Stability
REGULATORY AND COMPENDIAL FRAMEWORK
Science-based development designed around intended use, scientific risk, and fit-for-purpose validation
Quantum Analytics Group method development and validation services are designed around the analytical target, the method's intended use, product development stage, analytical risk, transfer requirments, and applicable regulatory or compendial expectations.
Development and Validation
ICH Q14, Analytical Procedure Development
ICH Q2(R2), Validation of Analytical Procedures
Applicable FDA and CDER anlytical method guidance
Client-defined quality and acceptance requirements
Transfer and Verification
USP<1224>, Transfer of Analytical Procedures
USP<1226>, Verification of Compendial Procedures
Applicable USP-NF monographs and General Chapters
Predefined laboratory acceptance and equivalency criteria
Stability-Indicating Methods
ICH Q1A(R2), StabilityTesting of New Drug Substantances and Products
Stress testing and forced degradation study design
Evaluation of degradation pathways and analytical specificity
Fit-For-Purpose—Not One-Size-Fits-All
Not every project requires every study or validation characteristic. Before work begins, Quantum works with the client to define intended use, performance requirements, acceptance criteria, documentation, and applicable regulatory or compendial considerations.
PROJECT DELIVERABLES
Clear documentation your team can use
The final method development/validation/verification documentation should be defined during project scoping. Depending on the engagement, deliverables may include:
Project scope and analytical development plan
Analytical target profile or performance requirements
Development experiments and scientific rationale
Final analytical procedure
Validation or verification protocol
Predefined acceptance criteria
System-suitabiliy requirements
Raw and processed data
Statistical analysis
Final development and validation reports
Method tranfer protocol and report
Technical consulting during implementation
CASE STUDY: API METHOD TRANSFR AND COMPARISION
Helping an API manufacturer respond to FDA questions with the right data
When the FDA questioned an in-house method used for a well-known generic antibiotic API, the manufacturer need more than laboratory testing. It needed a defensible transfer protoocol, a comparative study against the then current USP monograph method, and guidance on presenting the requested information without creating unnecessary regulatory questions.

The Regulatory Challenge
The manufacturer had submitted supporting data for its in-house HPLC-UV impuritymethod as part of an ANDA. Upon review, the FDA requested additional data, including a side-by-side comparison with the USP method to demonstrate equivalance.
The Technical Complication
The USP procedure used a dual-electrode coulomeric detector. This electrochemical techniques can be sensitive to electrode deterioration, fouling, temperature changes, mobile-phase impurities, and electoactive contamination within the chromatography system.
Quantum's Assignment
Quantum was recommended as a resource with experience in complex and unusual analytical methodologies. Quantum's team was asked to generate the necessary comparative data and guide the supporting submission work.
A controlled, fit-for-purpose approach
Rather than producing a larger volume of data than the agency had requested, Quantum focused the program on specific evidence needed to answer the FDA's questions. This reduced the risk that unnecessary information would introduce additional issues or complicate the response.
Method transfer first
Quantum developed a formal protocol to transfer the client's HPLC-UV method into our own laboratory. The protocol defined:
- Expected method performance
- Aceptance criteria for each participating laboratory
- Equivalence criteria between the originating and receiving laboratories
- The evidence (supporting data) required before beginning the comparative study.
Why the transfer mattered
A comparison between two methods is only meaningful when the client method has first been shown to perform reproducibly in the receiving laboratory. By establishing transfer acceptance and laboratory-equivalence criteria, Quantum created a defensible foundation for the subsequent USP comparison.
After successful transfer, Quantum performed the side-by-side evaluation of the client's HPLC-UV procedure and the USP coulometric method.
Outcome
The manufacturere received a structured method-transfer package and the comparative analytical data needed to address the FDA request.
Business value
Quantum helped the client protect its production timeline by translating a regulatory question into a focused analytical program rather than an open-ended testing excercise.
Quantum advantage
The engagement combined analytical method transfer, complex detector expertise, comparison-study design, predefined equivalence criteria, and practical regulatory-response support.
START A CONVERSATION
Bring Clarity to Your Product Challenges
Have a product, method, analytical or testing issue? Schedule FREE consultation with our team by submitting the form on this page. We’ll discuss your challenges, walk you through potential testing strategies, and help you move forward with confidence.
Monmouth Junction, NJ 08852
Corp & Admin Offices:
30 N Gould Street Suite 10683
Sheridan, WY 82801 USA
.png?width=100&height=104&name=Frame%204%20(1).png)
